EGFR and Miyoshi myopathy: Notably, some co-mutations, such as TP53/EGFR, TP53/RB1, TP53/ERBB2, and TP53/KMT2C, also occurred more frequently in the GI group, which correlated with higher GI scores and a worse prognosis, although sole mutations did not have a significant impact on patient prognosis, which implied that GI-related distinct genetic mutation patterns affect the clinical outcome of solid tumor patients with MM and should be further investigated in the future.